Cervical Dysplasia - Pipeline Insight, 2018 Research Report - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Aug 24, 2018--The “Cervical Dysplasia - Pipeline Insight, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.
‘Cervical Dysplasia - Pipeline Insight, 2018’ report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cervical Dysplasia development.
The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.
Key Topics Covered:
1. Report Introduction
2. Cervical Dysplasia Overview
3. Pipeline Therapeutics
4. Comparative Analysis
5. Products In Clinical Stage
6. Products In Pre-Clinical And Discovery Stage
7. Therapeutic Assessment
8. Inactive Products
Companies MentionedGenexine Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Shanghai Zerun Biotechnology Co. THEVAX Genetics Vaccine DFB Soria Inovio Pharmaceuticals Advaxis
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/zvrg6x/cervical?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180824005245/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Women’s Health
INDUSTRY KEYWORD: HEALTH GENERAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/24/2018 10:25 AM/DISC: 08/24/2018 10:25 AM